Jim Lim

Jim Lim joined Greenspring Associates in October 2004. Previously he was a Director at Commonfund Capital， a fund-of-funds firm that， as of the time of his departure， managed nearly $5.5 billion in commitments across venture capital， private equity， international private capital and natural resources programs. While at Commonfund Capital， Jim helped lead the due diligence efforts on many of the firm's top tier venture capital managers. He also spent three years at Pfizer where he was primarily responsible for managing the private capital portfolio of Pfizer's $2.5 billion pension plan. On behalf of the pension plan， Jim made commitments to funds managed by some of the leading venture capital and buyout managers in the industry. In addition to his pension fund experience， Jim had several corporate finance assignments in Pfizer's Research and Development Group and Pfizer's Operational， Planning and Analysis Group.

Jim is a cum laude graduate of Washington College where he received his degree in Economics and a graduate of Indiana University， where he received his MBA in Finance. Jim serves on the board of Columbia Capital， Delphi Ventures， Fairhaven Capital， Foundry Group， IPV Capital， Meritech Capital Partners， OpenView Venture Partners and O'Reilly AlphaTech Ventures. Jim also is a board observer of AtTask， BARRX Medical， ExactTarget and SkinMedica.